VGF, a new player in: Antidepressant action?

Science Signaling

Volumn 1, Issue 18, 2008, Pages

  Malberg, Jessica E ^a   Monteggia, Lisa M ^b  

^a PSYCHOGENICS INC   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NEUROPEPTIDE; VGF PEPTIDE;

ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; HUMAN; MAJOR DEPRESSION; METABOLISM; NERVE CELL; NERVE CELL PLASTICITY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE KINASE KINASES; NEURONAL PLASTICITY; NEURONS; NEUROPEPTIDES; SIGNAL TRANSDUCTION;

EID: 48149112170     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/stke.118pe19     Document Type: Review

References (24)

1. R. C. Kessler, P. Berglund, O. Demler, R. Jin, D. Koretz, K. R. Merikangas, A. J. Rush, E. E. Walters, P. S. Wang, The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095-3105 (2003).
2. H. K. Manji, W. C. Drevets, D. S. Charney, The cellular neurobiology of depression. Nat. Med. 7, 541-547 (2001).
3. E. J. Nestler, M. Barrot, R. J. Dileone, A. J. Eisch, S. J. Gold, L. M. Monteggia, Neurobiology of depression. Neuron 34, 13-25 (2002).
4. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IVTR) (American Psychiatric Publishing, Inc., Washington, DC, 2000).
5. N. S. Kline, Clinical experience with iproniazid (Marsilid). J. Clin. Exp. Psychopathol. 19, 72-78 (1958).
6. S. Rosenzweig-Lipson, C. E. Beyer, Z. A. Hughes, X. Khawaja, S. J. Rajarao, J. E. Malberg, Z. Rahman, R. H. Ring, L. E. Schechter, Differentiating antidepressants of the future: Efficacy and safety. Pharmacol. Ther. 113, 134-153 (2007).
7. L. E. Schechter, R. H. Ring, C. E. Beyer, Z. A. Hughes, X. Khawaja, J. E. Malberg, R. Rosenzweig- Lipson, Innovative approaches for the development of antidepressant drugs: Current and future strategies. NeuroRx 2, 590-611 (2005).
8. R. S. Duman, G. R. Heninger, E. J. Nestler, A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54, 597-606 (1997).
9. H. K. Manji, G. J. Moore, G. Rajkowska, G. Chen, Neuroplasticity and cellular resilience in mood disorders. Mol. Psychiatry 5, 578-593 (2000).
10. M. Adachi, M. Barrot, A. E. Autry, D. Theobald, L. M. Monteggia, Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol. Psychiatry 63, 642-649 (2008).
11. R. S. Duman, L. M. Monteggia, A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59, 1116-1127 (2006).
12. J. E. Malberg, J. A. Blendy, Antidepressant action: To the nucleus and beyond. Trends Pharmacol. Sci. 26, 631-638 (2005).
13. L. M. Monteggia, M. Barrot, C. M. Powell, O. Berton, V. Galanis, T. Gemelli, S. Meuth, A. Nagy, R. W. Greene, E. J. Nestler, Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc. Natl. Acad. Sci. U.S.A. 101, 10827-10832 (2004).
14. K. Q. Tanis, R. S. Duman, Intracellular signaling pathways pave roads to recovery for mood disorders. Ann. Med. 39, 531-544 (2007).
15. M. J. Chen, A. A. Russo-Neustadt, Running exercise- and antidepressant-induced increases in growth and survival-associated signaling molecules are IGF-dependent. Growth Factors 25, 118-131 (2007).
16. M. P. Mattson, S. Maudsley, B. Martin, A neural signaling triumvirate that influences ageing and age-related disease: Insulin/IGF-1, BDNF and serotonin. Ageing Res. Rev. 3, 445-464 (2004).
17. J. G. Hunsberger, S. S. Newton, A. H. Bennett, C. H. Duman, D. S. Russell, S. R. Salton, R. S. Duman, Antidepressant actions of the exercise-regulated gene VGF. Nat. Med. 13, 1476-1482 (2007).
18. S. Thakker-Varia, J. J. Krol, J. Nettleton, P. M. Bilimoria, D. A. Bangasser, T. J. Shors, I. B. Black, J. Alder, The neuropeptide VGF produces antidepressant- like behavioral effects and enhances proliferation in the hippocampus. J. Neurosci. 27, 12156-12167 (2007).
19. J. Alder, S. Thakker-Varia, D. A. Bangasser, M. Kuroiwa, M. R. Plummer, T. J. Shors, I. B. Black, Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J. Neurosci. 23, 10800-10808 (2003).
20. S. R. Salton, G. L. Ferri, S. Hahm, S. E. Snyder, A. J. Wilson, R. Posssenti, A. Levi, VGF: A novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance. Front. Neuroendocrinol. 21, 199-219 (2000).
21. S. E. Snyder, J. E. Pintar, S. R. Salton, Developmental expression of VGF mRNA in the prenatal and postnatal rat. J. Comp. Neurol. 394, 64-90 (1998).
22. J. E. Malberg, A. J. Eisch, E. J. Nestler, R. S. Duman, Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20, 9104-9110 (2000).
23. T. Saarelainen, P. Hendolin, G. Lucas, E. Koponen, M. Sairanen, E. MacDonald, K. Agerman, A. Haapasalo, H. Nawa, R. Aloyz, P. Ernfors, E. Castren, Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 23, 349-357 (2003).
24. J. F. Cryan, A. Markou, I. Lucki, Assessing antidepressant activity in rodents: Recent developments and future needs. Trends Pharmacol. Sci. 23, 238-245 (2002).